Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity
D. H. Quan, C. Counoupas, G. Nagalingam, R. Pinto, N. Petrovsky, W. J. Britton, J. A. Triccas
This study evaluates Advax adjuvant formulations for tuberculosis vaccine efficacy, showing they provide strong protection without causing inflammation or reactogenicity.
bioRxiv · Oct 1, 2020Immunology